Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure
Circulation: Heart Failure · 2026-06 · 19 (6)
DOI: 10.1161/circheartfailure.125.014117 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Heart Failure, 2026-06. Verfasst von Deepak K Gupta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Translational and Clinical Cardiovascular Research Center and Division of Cardiovascular Medicine (D.K.G., L.W.S.), Vanderbilt University …. Hauptthemen laut MEDLINE: Aminobutyrates, Heart Failure, Tetrazoles, Bradykinin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Symptomatic hypotension can limit sacubitril/valsartan therapy. Neprilysin inhibition may augment vasodilators, such as bradykinin. We hypothesized that bradykinin contributes to blood pressure (BP) lowering with sacubitril/valsartan in stable ambulatory patients with heart failure and reduced ejection fraction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt Translational and Clinical Cardiovascular Research Center and Division of Cardiovascular Medicine (D.K.G., L.W.S.), Vanderbilt University Medical Center, Nashville, TN.
- Division of Endocrinology, Diabetes, and Metabolism (E.M.G.), Vanderbilt University Medical Center, Nashville, TN.
- Division of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT (C.M.).
- Department of Biostatistics (H.N.), Vanderbilt University Medical Center, Nashville, TN.
- Division of Clinical Pharmacology (P.R.W., S.W.), Vanderbilt University Medical Center, Nashville, TN.
- Division of Metabolism, Endocrinology, and Diabetes, University of Michigan School of Medicine, Ann Arbor (A.F.T.).
ORCID-Profile: Deepak K Gupta, Lynne W Stevenson, Erica M Garner, Christopher Maulion, Hui Nian, Adina F Turcu, Nancy J Brown
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Gupta, D. K., Stevenson, L. W., Garner, E. M., Maulion, C., Nian, H., Wright, P. R., Turcu, A. F., Wei, S., & Brown, N. J. (2026). Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure. Circulation: Heart Failure, 19(6). https://doi.org/10.1161/circheartfailure.125.014117
Vancouver
Gupta DK, Stevenson LW, Garner EM, Maulion C, Nian H, Wright PR, et al. Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure. Circulation: Heart Failure. 2026;19(6). doi:10.1161/circheartfailure.125.014117
BibTeX
@article{Gupta2026,
author = {Gupta, Deepak K and Stevenson, Lynne W and Garner, Erica M and Maulion, Christopher and Nian, Hui and Wright, Patricia R and Turcu, Adina F and Wei, Shouzou and Brown, Nancy J},
title = {Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure},
journal = {Circulation: Heart Failure},
year = {2026},
volume = {19},
number = {6},
doi = {10.1161/circheartfailure.125.014117}
}
EUVIMED